XML 97 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
Related Party Transactions - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Jan. 31, 2016
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Related Party Transaction [Line Items]        
Preferred stock shares issued to related party (shares)   0 0  
Novartis Institutes for Biomedical Research, Inc.        
Related Party Transaction [Line Items]        
Payment for reimbursement of manufacturing costs incurred   $ 0 $ 0  
Novartis Institutes for Biomedical Research, Inc. | Novartis Collaboration        
Related Party Transaction [Line Items]        
Amounts due from related party   0 0  
Payment for reimbursement of manufacturing costs incurred   $ 0 0 $ 0
Novartis Institutes for Biomedical Research, Inc. | Novartis Collaboration | Minimum        
Related Party Transaction [Line Items]        
Percentage of share holding 5.00%      
Novartis Institutes for Biomedical Research, Inc. | Novartis Collaboration | Series A One Redeemable Convertible Preferred Stock        
Related Party Transaction [Line Items]        
Preferred stock shares issued to related party (shares) 2,000,000      
Gross proceeds from issuance of preference stock $ 13,500,000      
Novartis Institutes for Biomedical Research, Inc. | Novartis Collaboration | Private Placement        
Related Party Transaction [Line Items]        
Issuance of common stock (shares)   766,666    
Share price (in dollars per share) $ 15.00      
Proceeds from collaboration arrangement $ 11,500,000      
Vaccinex, Inc.        
Related Party Transaction [Line Items]        
Due to related party   $ 0 0  
Vaccinex, Inc. | Vaccinex License Agreement | Research and development expenses        
Related Party Transaction [Line Items]        
Payments to related party   850,000    
Vaccinex, Inc. | Vaccinex Research Agreement | Research and development expenses        
Related Party Transaction [Line Items]        
Payments to related party   $ 50,000 $ 50,000 $ 606,000